SCIT with a high-dose house dust mite allergoid is well tolerated: safety data from pooled clinical trials and more than 10 years of daily practice analyzed in different subgroups

about

SCIT with a high-dose house dust mite allergoid is well tolerated: safety data from pooled clinical trials and more than 10 years of daily practice analyzed in different subgroups

Item

http://www.wikidata.org/entity/Q57193203

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

SCIT with a high-dose house du ...... nalyzed in different subgroups

@en

SCIT with a high-dose house du ...... nalyzed in different subgroups

@nl

type

Item

label

SCIT with a high-dose house du ...... nalyzed in different subgroups

@en

SCIT with a high-dose house du ...... nalyzed in different subgroups

@nl

prefLabel

SCIT with a high-dose house du ...... nalyzed in different subgroups

@en

SCIT with a high-dose house du ...... nalyzed in different subgroups

@nl

P1476

SCIT with a high-dose house du ...... nalyzed in different subgroups

@en

P2093

Gabriele-Cornelia Fox

http://www.w3.org/2001/XMLSchema#string

Ludger Klimek

http://www.w3.org/2001/XMLSchema#string

Susanne Thum-Oltmer

http://www.w3.org/2001/XMLSchema#string

P2860

House Dust Mite Respiratory Allergy: An Overview of Current Therapeutic Strategies

Review on immunotherapy in airway allergen sensitised patients

Guideline on allergen-specific immunotherapy in IgE-mediated allergic diseases: S2k Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Society for Pediatric Allergy and Environmental Medicine (GPA), the Medical Asso

Allergen immunotherapy for allergic asthma: protocol for a systematic review

House dust mite sublingual tablet is effective and safe in patients with allergic rhinitis

Efficacy of a House Dust Mite Sublingual Allergen Immunotherapy Tablet in Adults With Allergic Asthma: A Randomized Clinical Trial.

Safety of house dust mite sublingual immunotherapy standardized quality tablet in children allergic to house dust mites.

Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines-2016 revision.

Effective treatment of house dust mite-induced allergic rhinitis with 2 doses of the SQ HDM SLIT-tablet: Results from a randomized, double-blind, placebo-controlled phase III trial.

Steroid-sparing effects with allergen-specific immunotherapy in children with asthma: a randomized controlled trial.

P2888

s40629-018-0059-x

P304

131-139

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40629-018-0059-X

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30294519

http://www.w3.org/2001/XMLSchema#string

P932

6153715

http://www.w3.org/2001/XMLSchema#string